Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 623-627

  Nonkwelo, Carol ^a   Skinner, Julia ^c   Bell, Andrew ^c   Rickinson, Alan ^c   Sample, Jeffery ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; MESSENGER RNA; VIRUS ANTIGEN;

ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION INITIATION; VIRUS INFECTION;

ANTIGENS, VIRAL; BINDING SITES; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VIRUS LATENCY;

EID: 0029656132     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.623-627.1996     Document Type: Article

References (31)

1. Bodescot, M., M. Perricaudet, and P. Farrell. 1987 A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. J. Virol 61: 3424-3430.
2. Chen, C.-L, R. H. Sadler, D. M. Walling, I.-J. Su, H.-C. Hsieh, and N. Raab-Traub. 1993. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol. 67:6303-6308.
3. Chen, F., J.-Z. Zou, L. di Renzo, G. Winberg, L.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1 J. Virol. 69:3752-3758.
4. Deacon, E. M., G. Pallesen, G. Niedobitek, J. Crocker, L. Brooks, A. B. Rickinson, and L. S. Young. 1993. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp Med. 177:339-349.
5. Fahraeus, R., H. Li-Fu, I. Ernberg, J. Finke, M. Rowe, G. Klein, K. Falk, E. Nilsson, M. Yadaf, P. Busson, T. Tursz, and B. Kallin. 1988. Expression of the Epstein-Barr virus genome in nasopharyngeal carcinoma. Int J. Cancer 42:329-338.
6. Gregory, C., M. Rowe, and A. Rickinson. 1990 Different Epstein-Barr virus (EBV)-B cell interactions in phenotypically distinct clones of a Burkphoma cell line. J. Gen. Virol. 71:1481-1495.
7. Hitt, M., M. Allday, T. Hara, L. Karran, M. Jones, P. Busson, T. Tursz, I. Ernberg, and B. Griffin. 1989. EBV gene expression in an NPC-related tumour EMBO J 8:2639-2651.
8. Kenney, S., J. Kamine, E. Holley-Guthrie, J.-C. Lin, E.-C. Mar, and J. Pagano. 1989. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J. Virol. 63:1729-1736.
9. Khanna, R., S. R. Burrows, M. G. Kurilla, C. A. Jacob, I. S. Misko, T. B. Sculley, E. Kieff, and D. J. Moss. 1992. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development J. Exp. Med 176:169-176.
10. Kieff, E., and D. Liebowitz. 1990. Epstein-Barr virus and its replication, p. 1889-1920. In B. Fields, D Knipe, R. Chanock, M. Hirsch. J Melnick, T. Monath, and B Roizman (ed.), Virology, 2nd ed. Raven Press Ltd., New York.
11. Lear, A. L., M. Rowe, M. G. Kurilla, S. Lee, S. Henderson, E. Kieff, and A. B. Rickinson. 1992 The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J. Virol. 66:7461-7468.
12. Murray, R., M. Kurilla, J. Brooks, W. Thomas, M. Rowe, E. Kieff, and A. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV positive malignancies J. Exp. Med. 176:157-168
13. Nonkwelo, C., E. B. D. Henson, and J. Sample. 1995. Characterization of the Epstein-Barr virus Fp promoter Virology 206:183-195.
14. Pallesen, G., S. J. Hamilton-Dutoit, M. Rowe, and L. S. Young. 1991. Expression of the Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 337:320-322.
15. Rooney, C., M. Rowe, L. Wallace, and A. Rickinson. 1985. Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance. Nature (London) 317:629-631.
16. Rowe, D., M. Rowe, G. Evan, L. Wallace, P. Farrell, and A. Rickinson. 1986. Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. EMBO J 5:2599-2607.
17. Sample, J., L. Brooks, C. Sample, L. Young, M. Rowe, C. Gregory, A. Rickinson, and E. Kieff. 1991. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. USA 88:6343-6347.
18. Sample, J., E. B. D. Henson, and C. Sample. 1992. The Epstein-Barr virus nuclear protein 1 promoter active in type 1 latency is autoregulated. J. Virol. 66:4654-4661
19. Sample, J., M. Hummel, D. Braun, M. Birkenbach, and E. Kieff. 1986 Nucleotide sequences of messenger RNAs encoding Epstein-Barr virus nuclear proteins, a probable transcriptional imitation site. Proc Natl. Acad Sci. USA 83:5096-5100.
20. Sample, J., and E. Kieff. 1990. Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes. J Virol. 64:1667-1674.
21. Sample, J., G. Lancz, and M. Nonoyama. 1986. Mapping of genes in BamHI fragment M of Epstein-Barr virus DNA that may determine the fate of viral infection. J Virol. 57:145-154
22. 21a.Schacfer, B. C., and S. H. Speck. 1994. Presented at the Cold Spring Harbor Meeting on Epstein-Barr Virus and Associated Diseases.
23. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J. Virol. 69:5039-5047.
24. Schaefer, B. C., M. Woisetschlaeger, J. L. Strominger, and S. H. Speck. 1991. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc. Nail Acad. Sci. USA 88:6550-6554.
25. Sinclair, A. J., M. Brimmell, and P. J. Farrell. 1992 Reciprocal antagonism of steroid hormones and BZLF1 in switch between Epstein-Barr virus latent and productive cycle gene expression. J. Virol. 66:70-77.
26. Smith, P., and B. Griffin. 1991 Differential expression of Epstein-Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells. Nucleic Acids Res 19:2435-2440.
27. Smith, P. R., and B. E. Griffin. 1992. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells J. Virol. 66:706-714.
28. Sung, N. S., J. Wilson, M. Davenport, N. D. Sista, and J. S. Pagano. 1994. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol. Cell Biol 14:7144-7152.
29. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994 Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol 68:7374-7385.
30. Woisetschlaeger, M., C. Vandava, L. Furmanski, J. Strominger, and S. H. Speck. 1990 Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA 87:1725-1729.
31. Young, L., C. Dawson, D. Clark, H. Rupani, P. Busson, T. Tursz, A. Johnson, and A. Rickinson. 1988 Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen Virol 69:1051-1065